Company Filing History:
Years Active: 2017-2019
Title: Innovations by Carlos C. Chang in Prosthetic Tissue Valves
Introduction
Carlos C. Chang, an accomplished inventor based in Atlanta, GA, has made significant contributions to the field of medical devices, particularly in the development of prosthetic tissue valves. With a total of six patents to his name, his innovations reflect a commitment to advancing cardiovascular health.
Latest Patents
Among his latest patents are two notable designs for prosthetic tissue valves. The first is a prosthetic valve featuring a conical shaped sheet member composed of an extracellular matrix (ECM) composition. This design includes multiple open slit regions arranged uniformly along linear planes parallel to the valve's longitudinal axis, with a proximal annulus engagement end diameter and length ratio ranging from 5:1 to 2:1. The second patent also describes a prosthetic valve with a cone-shaped sheet member made of ECM. This design incorporates ribbons projecting from the proximal end, with the distal ends of these ribbons positioned closely together, enhancing the functionality and performance of the valve.
Career Highlights
Carlos C. Chang has devoted his career to innovation in cardiovascular devices, leading to his position at CoMatrix Cardiovascular, Inc. His work has been pivotal in addressing the challenges associated with prosthetic heart valves, ultimately contributing to improved patient outcomes in cardiovascular surgeries.
Collaborations
Throughout his career, Chang has collaborated with notable colleagues, including Robert G. Matheny and Minh X. Vo, further enriching the innovation landscape within his field. These partnerships have fostered an environment of creativity and progress in developing advanced medical solutions.
Conclusion
Carlos C. Chang continues to push the boundaries of medical device innovation, especially in the realm of prosthetic tissue valves. His patents represent not only his expertise but also his dedication to improving patient care through cutting-edge technologies. As he continues his work at CoMatrix Cardiovascular, Inc., the medical community looks forward to his future contributions to the field.